Core Viewpoint - Lutai A (000726.SZ) has sold financial assets to improve liquidity, with the sale of Rongchang Biotech shares impacting net profit by 81.04 million yuan, exceeding 10% of the company's audited net profit for the last fiscal year [1][3]. Financial Performance - In 2024, Lutai A achieved revenue of 6.091 billion yuan, a year-on-year increase of 2.17%, and a net profit of 410 million yuan, up 1.7% [1][6]. - The company completed a total cash dividend distribution of 204 million yuan for 2024, representing approximately 49.84% of the net profit for the year [1][8]. Shareholding and Asset Management - As of December 31, 2024, Lutai A held 3.918 million shares of Rongchang Biotech, accounting for 0.72% of its total equity, with a book value of 118 million yuan [2][3]. - Following the sale, Lutai A retains 612,600 shares of Rongchang Biotech [2][3]. Market Activity - The stock price of Rongchang Biotech fell by 18.36% on June 26, 2024, closing at 60.7 yuan per share, despite a year-to-date increase of 97.85% [4]. - The current market value of Lutai A's remaining shares in Rongchang Biotech is approximately 37.185 million yuan [4]. Business Operations - Lutai A's textile and apparel segment generated revenue of 5.707 billion yuan in 2024, reflecting a 2.74% increase, with fabric and clothing products contributing 4.335 billion yuan and 1.372 billion yuan, respectively [6]. - The production volumes for fabrics and shirts were 205 million meters and 18.2526 million pieces, showing growth of 1.45% and 3.18% year-on-year [6]. Investment and Capital Management - Lutai A raised 1.4 billion yuan through convertible bonds in 2020, with net proceeds of 1.388 billion yuan allocated to strategic projects [7]. - The company has invested 586 million yuan and 358 million yuan in its functional fabric smart eco-park and overseas high-end fabric product line projects, respectively, with both projects having exceeded their investment targets [7]. Share Buyback and Dividends - In 2024, Lutai A repurchased B-shares for a total of 37.867 million yuan, contributing to a total cash distribution (dividends and buybacks) of 242 million yuan, which is 59.03% of the net profit for the year [8].

Core Viewpoint - The company, Lutai Textile Co., Ltd., plans to sell its shares in Rongchang Biological to improve asset liquidity and efficiency, and to meet operational funding needs. The sale will be conducted through the secondary market at a reasonable price range, with specific details such as timing and transaction amounts remaining uncertain [1][5]. Transaction Overview - The company holds 3,918,265 shares of Rongchang Biological, accounting for 1.25% of its total equity. The sale does not require board approval and does not constitute a related party transaction or a major asset restructuring [2][3]. - The estimated profit from the stock sale is projected to impact the company's net profit by approximately 81.04 million yuan, exceeding 10% of the audited net profit for the last fiscal year, thus meeting disclosure standards [2][3]. Basic Information of the Transaction Target - Rongchang Biological was established on July 4, 2008, and is located in Yantai, Shandong. It focuses on the discovery, development, and commercialization of innovative biopharmaceuticals for major diseases [3]. - As of March 31, 2025, Rongchang Biological's total assets were approximately 5.5 billion yuan, with total liabilities of about 3.5 billion yuan, resulting in a net asset value of approximately 1.99 billion yuan [4]. Purpose and Impact of Asset Sale - The primary goal of selling the shares is to reduce the proportion of financial assets and to meet the company's funding requirements. The proceeds will be used to supplement working capital [5]. - The company currently holds 612,600 shares of Rongchang Biological, and while the sale may affect current profits, the final impact remains uncertain due to market volatility [5].

| | | 鲁泰纺织股份有限公司 关于出售金融资产情况的公告 公司及董事会全体成员保证公告内容的真实、准确和完整，对公告的虚假记载、误导 性陈述或者重大遗漏负连带责任。 特别提示： 1、荣昌生物制药(烟台)股份有限公司（以下简称"荣昌生物"）于 2022 年 3 月 30 日在上海证券交易所科创板上市，鲁泰纺织股份有限公司（以下简称"公司"）截至 2024 年 12 月 31 日持有荣昌生物 391.8265 万股，占其总股本的比例为 0.72%，公司持 有该股权的账面价值为 1.18 亿元，占公司最近一个会计年度经审计净资产的 1.25%。 2、从维护股东及公司利益出发，结合荣昌生物股票二级市场状况等因素，公司决 定在合理的价位区间通过二级市场竞价交易系统择机出售公司所持有的荣昌生物股份。 该股票资产账面价值占公司最近一个会计年度经审计净资产的比例低于 5%，无需提交 公司董事会审议，不构成关联交易，不构成重大资产重组，交易实施不存在重大法律 障碍。 公司截至 2024 年 12 月 31 日持有荣昌生物 391.8265 万股，占其总股本的比例为 0.72%，公司持有该股权的账面价值为 1.18 亿元，占 ...

Core Viewpoint - The company plans to sell 3.9183 million shares of Rongchang Biological through the secondary market starting from March 2025, representing 0.72% of its total share capital, with a book value of 118 million yuan [1] Summary by Relevant Sections Share Sale Details - The sale will be executed through a bidding system in the secondary market, with the timing, transaction price, transaction amount, and counterparties remaining uncertain [1] - The pricing for the sale will be based on market prices [1] Financial Impact - As of June 24, 2025, the profit generated from the sold shares is expected to impact the current net profit by 81.0445 million yuan, accounting for over 10% of the company's audited net profit attributable to shareholders for the most recent fiscal year [1] Regulatory Aspects - The transaction does not require approval from the company's board of directors, does not constitute a related party transaction, and does not qualify as a major asset restructuring [1] - There are no significant legal obstacles to the implementation of the transaction [1]

Group 1 - The company approved a profit distribution plan for the year 2024, proposing a cash dividend of 1.00 RMB per 10 shares, totaling 81,730,601 RMB [1][2] - The distribution will be based on the total share capital of 817,306,010 shares, with A shares receiving 59,118,004.50 RMB and B shares receiving 22,612,596.50 RMB [1][2] - The dividend will be distributed on June 20, 2025, with the ex-dividend date set for the same day [2] Group 2 - The cash dividends for B shares will be converted to Hong Kong dollars based on the exchange rate published by the People's Bank of China on May 8, 2025 [2] - The adjustment of the conversion price for the company's convertible bonds will occur due to the dividend distribution [3]

股票代码：000726、200726 股票简称：鲁泰A、鲁泰B 公告编号：2025-043 债券代码：127016 债券简称：鲁泰转债 鲁泰纺织股份有限公司 关于可转债转股价格调整的公告 鲁泰纺织股份有限公司及董事会全体成员保证本公告内容不存在任何虚假记载、误导性陈 述或重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 特别提示 债券代码：127016，债券简称：鲁泰转债 调整前转股价格：8.59 元/股 调整后转股价格：8.49 元/股 本次转股价格调整生效日期：2025 年 6 月 20 日 一、关于可转换公司债券转股价格调整的相关规定 鲁泰纺织股份有限公司（以下简称"公司"）于 2020 年 4 月 9 日公开发行了 1,400 万张可转换公司债券（债券简称：鲁泰转债，债券代码：127016），根据《鲁 泰纺织股份有限公司公开发行 A 股可转换公司债券募集说明书》的相关条款，以 及中国证券监督管理委员会关于公开发行可转换公司债券的有关规定，"鲁泰转债" 发行之后，若公司发生派送股票股利、转增股本、增发新股（不包括因本次发行的 可转换公司债券转股而增加的股本）、配股以及派发现金股利等情况， ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性 陈述或重大遗漏。 一、股东会审议通过利润分配方案等情况 1、鲁泰纺织股份有限公司2024年度利润分配方案已经2025年5月7日召开的 2024年年度股东大会审议通过。 证券代码：000726 200726 证券简称：鲁泰Ａ 鲁泰Ｂ 公告编号：2025-042 债券代码：127016 债券简称：鲁泰转债 本公司2024年度利润分配方案为：公司以股本817,306,010股为基数，每10 股派发现金红利1.00元（含税），以此计算的股息总额为81,730,601元。因公司 正处于可转换债券转股期间，故将以实施本次分配方案股权登记日的总股本为基 数进行利润分配，每股分配金额保持不变。 鲁泰纺织股份有限公司 2、本次利润分配方案与2024年年度股东大会审议通过的分配方案一致。 2024年度分红派息实施公告 二、本次实施的利润分配方案 公司2024年年度权益分派方案为：以公司现有总股本817,306,010股为基数 （其中，A股591,180,045股，B股226,125,965股），每10股分配现金1.00元人民 币（含税）,共计派发现金 ...

鲁泰A公告，公司2024年度利润分配方案已经股东大会审议通过。公司以8.17亿股为基数，每10股派发 现金红利1元(含税)，共计派发现金红利8173.06万元。其中，A股派发现金红利5911.8万元，B股派发现 金红利2261.26万元。A股QFII、RQFII、境外战略投资者、香港结算(深股通)以及持有首发前限售股的 个人和证券投资基金每10股派0.9元；持有首发后限售股、首发后可出借限售股、股权激励限售股及无 限售流通股的个人、证券投资基金股息红利税实行差别化税率征收，先按每10股派1元，权益登记日后 根据投资者减持股票情况，再按实际持股期限补缴税款；B股非居民企业扣税后每10股派现金0.9元，持 有无限售流通股的境内(外)个人股东的股息红利税实行差别化税率征收，先按每10股派1元，权益登记 日后根据投资者减持股票情况，再按实际持股期限补缴税款。本次权益分派A股股权登记日为2025年6 月19日，除权除息日为2025年6月20日；B股最后交易日为2025年6月19日，股权登记日为2025年6月24 日，除权除息日为2025年6月20日。 ...

股票代码：000726 200726 股票简称：鲁泰A 鲁泰B 公告编号：2025-041 债券代码：127016 债券简称：鲁泰转债 鲁泰纺织股份有限公司 公司及董事会全体成员保证公告内容的真实、准确和完整，对公告的虚假记载、误导性 陈述或者重大遗漏负连带责任。 一、董事会会议召开情况 鲁泰纺织股份有限公司（以下简称"公司"）第十一届董事会第一次会议通知于 阳山庄会议室召开，本次会议召开方式为现场与通讯表决。本次会议由公司董事长刘 子斌先生主持，应出席董事 12 人，实际出席董事 12 人：其中现场出席 9 人，通讯表 决 3 人，董事许植楠、许健绿、郑会胜以通讯方式表决。公司部分高管列席了本次会 议。公司会议通知及召开程序符合《中华人民共和国公司法》、《鲁泰纺织股份有限 公司章程》等有关规定，会议决议合法有效。 （3）薪酬与考核委员会：会议选举刘子斌、于明涛、朱北娜、权玉华、魏建为薪 酬与考核委员会委员。朱北娜为薪酬与考核委员会主席。 上述人员任期三年。 二、董事会会议审议情况 本次会议审议通过了以下议案： 果：12 票同意，0 票反对，0 票弃权。 许植楠先生为副董事长，任期三年。 票同意，0 票反对， ...

北京德和衡（青岛）律师事务所 关于鲁泰纺织股份有限公司 法律意见书 德和衡证见意见（2025）第00139号 BEIJING DHH LAW FIRM 地址：山东省青岛市香港中路 2 号海航万邦中心 1 号楼 50 层 北京德和衡（青岛）律师事务所 关于鲁泰纺织股份有限公司 法律意见书 德和衡证见意见（2025）第 00139 号 致：鲁泰纺织股份有限公司 北京德和衡（青岛）律师事务所（以下简称"本所"）接受鲁泰纺织股份有 限公司（以下简称"公司"）的委托，指派曹钧律师、包宇航律师（以下简称"本 所律师"）出席公司2025年第一次临时股东会（以下简称"本次股东会"），并 根据《中华人民共和国公司法》《中华人民共和国证券法》等法律、法规和规范 性文件以及《鲁泰纺织股份有限公司章程》（以下简称《公司章程》）的规定， 就公司本次股东会的召集、召开程序、召集人的资格、出席会议人员的资格及表 决程序、表决方式、表决结果等有关事宜进行见证并出具本法律意见书。 本法律意见书仅就本次股东会的召集和召开程序、会议召集人和出席会议 人员的资格、会议表决程序、表决方式和表决结果的合法有效性等发表意见， 并不对本次股东会所审议的议案 ...